Montes et al. observed that PD-L1 levels on peripheral blood (PB) CD34+ cells were comparable between different disease stages of MDS and even higher in MDS than in secondary AML (sAML) [69]. The gene discussed is CD274; the disease is myelodysplastic syndrome.